Cargando…
CD5 molecule-like and transthyretin as putative biomarkers of chronic myeloid leukemia - an insight from the proteomic analysis of human plasma
Better and sensitive biomarkers are needed to help understand the mechanism of disease onset, progression, prognosis and monitoring of the therapeutic response. Aim of this study was to identify the candidate circulating markers of chronic-phase chronic myeloid leukemia (CP-CML) manifestations, havi...
Autores principales: | Fatima, Iram, Sadaf, Saima, Musharraf, Syed Ghulam, Hashmi, Naghma, Akhtar, Muhammad Waheed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5259771/ https://www.ncbi.nlm.nih.gov/pubmed/28117336 http://dx.doi.org/10.1038/srep40943 |
Ejemplares similares
-
5D proteomic approach for the biomarker search in plasma: Acute myeloid leukaemia as a case study
por: Raza, Syed Kashif, et al.
Publicado: (2017) -
Circulating miR-146a expression as a non-invasive predictive biomarker for acute lymphoblastic leukemia
por: Shahid, Samiah, et al.
Publicado: (2021) -
Clinical proteomics of myeloid leukemia
por: Hjelle, Sigrun M, et al.
Publicado: (2010) -
Stress degradation studies and development of stability-indicating TLC-densitometry method for determination of prednisolone acetate and chloramphenicol in their individual and combined pharmaceutical formulations
por: Musharraf, Syed Ghulam, et al.
Publicado: (2012) -
Comparative proteomics in acute myeloid leukemia
por: Luczak, Magdalena, et al.
Publicado: (2012)